Prudential Financial’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-122,239
Closed -$3.32M 2512
2019
Q2
$3.32M Buy
122,239
+115,187
+1,633% +$3.61M 0.01% 1338
2019
Q1
$245K Buy
+7,052
New +$203K ﹤0.01% 2262
2018
Q3
Sell
-83,782
Closed -$3.16M 2489
2018
Q2
$3.16M Sell
83,782
-45,040
-35% -$1.72M ﹤0.01% 1428
2018
Q1
$4.21M Buy
128,822
+12,826
+11% +$563K 0.01% 1240
2017
Q4
$5.49M Sell
115,996
-7,320
-6% -$370K 0.01% 1108
2017
Q3
$6.66M Buy
123,316
+33,180
+37% +$1.95M 0.01% 1029
2017
Q2
$5.06M Sell
90,136
-65,604
-42% -$2.63M 0.01% 1134
2017
Q1
$6.1M Sell
155,740
-136,970
-47% -$4.36M 0.01% 1039
2016
Q4
$6.57M Buy
292,710
+45,200
+18% +$883K 0.01% 999
2016
Q3
$5.62M Buy
247,510
+17,447
+8% +$410K 0.01% 1020
2016
Q2
$5.43M Buy
230,063
+94,521
+70% +$2.33M 0.01% 1064
2016
Q1
$2.77M Buy
135,542
+130,242
+2,457% +$4.13M ﹤0.01% 1401
2015
Q4
$273K Sell
5,300
-6,900
-57% -$335K ﹤0.01% 2089
2015
Q3
$520K Buy
12,200
+100
+0.8% +$4.83K ﹤0.01% 1934
2015
Q2
$551K Buy
12,100
+200
+2% +$8.05K ﹤0.01% 1940
2015
Q1
$452K Buy
+11,900
New +$409K ﹤0.01% 2008

Other funds holding PTLA

Prudential Financial's PTLA Position: Q3 2019 in Review

Prudential Financial sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2019, closing a stake of 122,239 shares — an estimated $3.32M sold.

Prudential Financial first reported a position in PTLA in Q1 2015 and held it in 16 quarters. The position peaked at $6.66M in Q3 2017. 212 funds tracked by Wall St. Rank hold PTLA as of Q3 2019.

  • Prudential Financial reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Prudential Financial sold 122,239 Portola Pharmaceuticals, Inc. shares in Q3 2019, an estimated $3.32M.
  • Prudential Financial first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 16 quarters.
  • Prudential Financial's Portola Pharmaceuticals, Inc. position peaked at $6.66M in Q3 2017.
  • 212 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2019.

Based on Prudential Financial's 13F filing for Q3 2019, filed 13 Nov 2019.